Press Releases
- Pulmotect Awarded $8.9 Million from The State of Texas
May 30, 2023 - Pulmotect Provides Results from Two Randomized, Placebo Controlled Phase-2 Trials of PUL-042 Against COVID-19
December 2, 2021 - Pulmotect Reports Positive Topline Results from Randomized, Placebo Controlled Phase-2 Trial of PUL-042 against COVID-19
September 21, 2021 - Pulmotect Appoints William J. Noss III as Chief Financial Officer
June 29, 2021 - Pulmotect Awarded Up To $6M From Department of Defense to Complete Two COVID-19 Trials
January 27, 2021 - Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
May 5, 2020 - Pulmotect’s PUL-042 Shows Promising Pre-Clinical Efficacy in Preventing Lethal Coronavirus Infection
January 27, 2020 - Dr. Colin Broom joins Pulmotect, Inc. as CEO
October 17, 2019 - AstraZeneca VP Kumar Srinivasan Joins Pulmotect, Inc. Board of Directors
October 17, 2019 - Pulmotect Announces Initial Close on $12 Million Series B
May 9, 2018
More Press Releases
